EUVIMEDEUVIMED entdecken
Crossref

Why has there been such a long delay in the implementation of population lung cancer screening in the USA?

Frederic W. Grannis

Academia Medicine · 21.03.2025 · 2 (1)

DOI: 10.20935/acadmed7560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academia Medicine, online erschienen am 21.03.2025. Verfasst von Frederic W. Grannis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 163 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When three National Cancer Institute (NCI)–sponsored research trials demonstrated a striking improvement in survival with chest radiographic screening (CRS) in the 1980s, critics questioned whether the results were tainted by biases, including overdiagnosis, and posited a long list of hypothetical risks, suggesting that lung cancer screening (LCS) would provide little benefit but might cause enormous harm. For more than 40 years, a relatively small cadre of individuals, often acting in concert, relentlessly opposed implementation of population CRS and later computerized tomographic lung cancer screening (CT LCS). Delays due to the completion of multiple randomized controlled trials; restriction of CT LCS to only those at the highest risk; hyperbolic fear of radiation carcinogenesis at low doses; the imposition of shared decision-making (SDM), including decision aids (DAs) incorporating misinformation; the COVID-19 epidemic; and an overly optimistic focus on molecular screening may have contributed to the long delay. In 2024, we have accumulated a large body of evidence demonstrating that CT LCS can prevent lung cancer (LC) deaths through early-stage detection, permitting effective and safe treatment. Yet, 40 years after initial reports of higher survival with radiographic screening, the number of high-risk individuals screened remains low in the USA. An opportunity to save countless lives has been lost.

Zitieren

APA

Grannis, F. W. (2025). Why has there been such a long delay in the implementation of population lung cancer screening in the USA?. Academia Medicine, 2(1). https://doi.org/10.20935/acadmed7560

Vancouver

Grannis FW. Why has there been such a long delay in the implementation of population lung cancer screening in the USA?. Academia Medicine. 2025;2(1). doi:10.20935/acadmed7560

BibTeX
@article{Grannis2025,
  author = {Grannis, Frederic W.},
  title = {Why has there been such a long delay in the implementation of population lung cancer screening in the USA?},
  journal = {Academia Medicine},
  year = {2025},
  volume = {2},
  number = {1},
  doi = {10.20935/acadmed7560}
}
Kostenlos starten →